Most Recent

image: Opinion: The Scientist’s Scarlet Letter

Opinion: The Scientist’s Scarlet Letter

By | December 16, 2016

Managing privacy protections and expectations in a misconduct proceeding

0 Comments

image: Mouse Immunology Paper Retracted

Mouse Immunology Paper Retracted

By | December 16, 2016

A finding of misconduct spurs the retraction of a Science paper claiming to have identified a protein in mice that boosted immunity to both viruses and cancer.

1 Comment

image: New Species of 2016

New Species of 2016

By | December 16, 2016

From a new Tyrannosaurus and many other dinosaurs to all of the living species named this year, researchers continue to chip away at the planet’s unknown biodiversity.

0 Comments

image: Slideshow: New Species of 2016

Slideshow: New Species of 2016

By | December 16, 2016

A look at some of the species named this year

0 Comments

image: Induced Pluripotent Stem Cells Show Signs of Donor Age

Induced Pluripotent Stem Cells Show Signs of Donor Age

By | December 12, 2016

iPSCs created through the reprogramming of human somatic cells retain genomic marks of the donor’s age.

0 Comments

image: Phages Carry Antibiotic Resistance Genes

Phages Carry Antibiotic Resistance Genes

By | December 8, 2016

Researchers find evidence of antibiotic resistance genes in the DNA of viruses that infect bacteria.

1 Comment

Lawyers involved discuss the latest twist in the ongoing litigation that pits pathologist Fazlul Sarkar against anonymous commenters on the post-publication peer review site.

1 Comment

Court of Appeals denies a motion filed by ACLU lawyers to enter the full Wayne State University investigation of pathologist Fazlul Sarkar into the official case record.

0 Comments

image: Infographic: Partitioning the Genome

Infographic: Partitioning the Genome

By | December 1, 2016

To make sense of the genetic variation within species, researchers are turning to the concept of the pangenome.

1 Comment

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

  4. Abundant Sequence Errors in Public Databases
Business Birmingham